Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study.
Isaac PascualFernando Carrasco-ChinchillaTomás Benito GonzálezChin Hion LiPablo AvanzasLuis Nombela-FrancoManuel PanAna Serrador FrutosXavier FreixaRamiro Trillo-NoucheRosa A Hernández-AntolínLeire Andraka IkazuriagaIgnacio Cruz-GonzalezJose Ramon Lopez-MinguezJose Luis Diez GilAlberto Berenguer-JofresaJuan SanchisValeriano Ruiz-QuevedoCristobal Urbano-CarrilloJuan F Oteo DominguezMaria R Ortas-NadalEduardo Molina NavarroXavier CarrilloJuan H Alonso-BrialesFelipe Fernández-VazquezLuis Asmarats SerraDaniel Hernández-VaqueroPilar Jimenez-QuevedoDolores MesaTania Rodríguez-GabellaAnder RegueiroAmparo Martinez MonzonísLuisa Salido TahocesLara Ruiz GomezBlanca Trejo-VelascoVictor M Becerra-MuñozCarmen Garrote-ColomaEstefania Fernández-PeregrinaRebeca LorcaJose A De AgustínMiguel RomeroIgnacio J Amat-SantosManel Sabaté TenasAna B Cid AlvarezJose M Hernandez-GarciaJavier GualisDabit ArzamendiCésar MorísGabriela Tirado-ConteAngel Sánchez-RecaldeRodrigo Estevez-LoureiroPublished in: Journal of clinical medicine (2020)
FMR patients with LVEF <30% treated with MitraClip® had higher mortality and readmissions than patients with LVEF ≥30% treated with the same device. However, both groups improved the NYHA functional class and MR severity.